N, S., Y, N., A, T., S, S., K, T., N, O., . . . K, N. (2021). Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press.
Cita Chicago Style (17a ed.)N, Shiratori, et al. Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press, 2021.
Cita MLA (8a ed.)N, Shiratori, et al. Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.